Showing 1 - 20 results of 94 for search '(( 200 greater decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (_ decrease)))) ))~', query time: 0.90s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Table_1_Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients.docx by Zhong-Xiu Wang (9729359)

    Published 2020
    “…Patients with a lower baseline National Institute of Health Stroke Scale (NIHSS) score (8.25 ± 5.57 vs. 13.51 ± 7.42, P < 0.001), a higher Alberta Stroke Program Early CT Score (ASPECTS; 8.65 ± 1.82 vs. 8.13 ± 2.00, P = 0.005), decreased BP during thrombolysis (69.4% vs. 59.8%, P = 0.037), and steady BP (SD < 10 mmHg) were more likely to have a favorable outcome (73.9% vs. 60.6%, P = 0.019). …”
  9. 9
  10. 10
  11. 11
  12. 12

    Muscovite <sup>40</sup>Ar/<sup>39</sup>Ar ages help reveal the Neogene tectonic evolution of the southern Annapurna Range, central Nepal by Aaron J. Martin (671213)

    Published 2016
    “…<p>We present new muscovite <sup>40</sup>Ar/<sup>39</sup>Ar ages from thirteen Greater Himalayan rocks and one Lesser Himalayan rock collected from four north-trending transects across the southern Annapurna Range. …”
  13. 13

    Mortality dataset used in analysis. by Samuel Sendagala (21417164)

    Published 2025
    “…The overall child mortality rate per 1,000 person-years was 5.0 (95% CI: 4.0--6.2) and was significantly greater among the infants exposed to HIV (14.2; 95% CI: 10.0--20.0) than among the infants not exposed to HIV (3.5; 95% CI: 2.6--4.6). …”
  14. 14

    Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Tao Cheng (1235148)

    Published 2016
    “…The onabotulinumtoxinA-treated groups had a significantly decreased mean number of urinary incontinence episodes per week (at week 6) (onabotulinumtoxinA200U: MD: -10.72, 95% CI: -13.4 to -8.04, P<0.00001; 300 U: MD: -11.42, 95% CI: -13.91 to -8.93, P<0.00001), MDP (200 U: MD: -33.46, 95% CI: -39.74 to -27.18, P<0.00001; 300 U: MD: -31.72, 95% CI: -37.69 to -25.75, P<0.00001), and greater increased MCC (200 U: MD: 141.30, 95% CI: 121.28 to 161.32, P<0.00001; 300 U: MD: 151.39, 95% CI: 130.43 to 172.34, P<0.00001) compared to the placebo-treated groups. …”
  15. 15

    Characteristics of women at admission. by Guiyou Yang (10259597)

    Published 2025
    “…In the 2 weeks window, the number of daily outcome events decreased from over 200 to around 10. For both PIERS-ML and fullPIERS models, we observed consistently higher mean risk in the adverse outcome (versus uncomplicated course) group. …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20